A newly developed gene therapy shows great potential for treating glaucoma, a condition that can lead to vision loss. The therapy protects retinal ganglion cells, essential for vision, and improves their function in animal models of glaucoma. It also enhances energy production in human retinal cells, which could prevent further damage. This therapy offers a new and promising approach to treating a condition that affects millions worldwide.